top of page
FutureMeds_Clinical_Trials_Home_Hero_bg.jpg

Therapy Areas

Therapy Area Expertise

Meet the leadership team driving clinical trial innovation across Europe

Oncology

Sub text

Blurb about our oncology expertise

shutterstock_1476281402 (1)_edited.png
Oncology

Iwona Tongbhoyai

Client Service Solutions Officer

Radoslaw studied medicine at the University of Warsaw graduating in 1997. After working as a hospital doctor for 4 years he moved into clinical research initially as a site director for a Polish CRO.  Working for Synexus from 2005 until 2019 he was responsible for the rapid growth of the business across Central and Eastern Europe. He was appointed COO in 2015.

Group 33915 (3).png
Iwona

Marcin Gondek

Chief Financial Officer

Marcin is a graduate in Economics from the University of Wroclaw.  He spent 10 years working in senior finance roles for a number of multinational companies.  He joined Synexus in 2012, initially as finance director for Central and Eastern Europe and has extensive knowledge of site operations, feasibility and contracting.  Marcin was appointed as CFO of Synexus in 2017 and lead the integration of the European and US businesses.

Marcin_Gondek_FutureMeds.webp
Marcin

Dr Torsten Sernau

VP of Medical Operations

With a successful track record spanning 28 years in the clinical research industry, Dr Torsten Sernau is responsible for nurturing relations with key Pharmaceutical clients, strategising our offerings across all therapeutic areas and enhancing the visibility of FutureMeds in the industry. Torsten brings a wealth of expertise and experience to bolster our medical operations and help FutureMeds address the internal complexities that come with the fast growth of our site network.

torsten_futuremeds.webp
Torsten

Paul Chambers

Chairman

Paul graduated from the University of Sheffield before training as a Chartered Accountant with KPMG.  He spent five years in Practice before moving into industry.  Formerly CFO of Synexus from 2010-2017, leading the business through a period of substantial growth culminating in two successful private equity exits. Paul is currently a non-executive director of The North West Fund.

Paul_Chmabers_FutureMeds.webp
Paul

Grzegorz Krówczyński

VP of IT

Grzegorz Krówczyński VP of IT LinkedIn With over 17 years of professional experience and deep domain knowledge of Business Intelligence, Data Management and Clinical Trial Management Systems, Grzegorz plays a key role in building FutureMeds' IT arm and ensuring that the company is fully prepared and ready for driving innovations in the Clinical Trials market.

Grzegorz_FutureMeds.webp
Grzeg

Rocio Diaz Sanchez

Managing Director, Spain

With over 12 years of experience in Research Management in different academic institutions and private hospitals, Rocio Diaz, in her role of Managing Director of FutureMeds Spain aims to bring the patients’ the best treatment. Through her continued commitment to excellence, Rocio strives to contribute further to the betterment of society.

Rocio_Diaz_FutureMeds.webp
Rocio

Nachiket Chandak

Senior Director of BD

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

nach_futuremeds.jpeg
Nach

Wojciech Szczepanik

VP of Site Operations

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Wojtek2_FutureMeds.jpeg
Wojtek

John Allen

Managing Director, United Kingdom

With over 15 years clinical research experience and a background as a qualified accountant, John brings a unique blend of expertise to our team. His commitment to high patient recruitment have been pivotal in establishing multiple sites for FutureMeds UK.  John Allen leadership and extensive knowledge are instrumental in making a positive impact in UK clinical research.

john_allen_FutureMeds.webp
John

Borislav Borissov MD MBA, DSc

Managing Director, Bulgaria

Prof. Dr. Borislav Borissov, MD, MBA, DSc, with over 31 years of medical and over 11 years of clinical trials management experience, will be responsible for leading FutureMeds’ Bulgarian operations and extending FutureMeds' network of medical research clinics into Bulgaria.

Borislav_Futuremeds.webp
Boris

Dr. Piotr Rozpondek MD PhD

Managing Director, Poland

As Managing Director of FutureMeds Poland, Piotr aims to further improve access for patients to clinical trials using virtual visits and home nursing, advance decentralized clinical trials processes, start hospital-based new sites, and introduce oncology studies to FutureMeds’ therapeutic areas.

Piotr_FutureMeds.webp
Piotr

Prof. Edward Czerwinski

Senior Medical Director

Edward is a Professor of the Jagiellonian University with 45+ years of experience as a practicing orthopaedic surgeon in addition to being an active university lecturer and scientist.  He founded the Krakow Medical Centre (KCM) in 1996 and has supervised over 200 trials acting as PI on 49. Edward serves on multiple scientific boards and has organised several international congresses, including the World Congress on Osteoporosis in 2018. He has authored in excess of 500 publications.

Prof_Edward_FutureMeds.webp
Edward

Ivan Vyshnyvetskyy MD Ph.D.

Managing Director, Ukraine

Ivan has over 20 years of experience in medical practice and clinical research. He is an Investigator with 50+ clinical trials experience, including 30+ trials as a PI and is the President of the Ukrainian Association for Clinical Research, which under his governance became the largest and most influential Ukrainian professional society in the field.

ivan_futuremeds.webp
Ivan

Małgorzata Herrera

Director of Feasibility & Proposals

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Małgorzata_Herrera_FutureMeds.jpeg
Maggie

Nicole Bohrmann

Director of Decentralized Operations

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

image 11 (3).png
Nicole

Ninon Armburst

Head of Sites, Germany

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

ninon_amburst_Futuremeds_edited.jpg
Ninon

Cameron Glen

VP of Global BD

Cameron has a unique blend of industry experience and knowledge. He spent 23 years of his career building & forging alliances and pursuing new business for notable public and private sector players such as Menarini Pharmaceuticals, AstraZeneca, University of Dundee/NHS Tayside, Synexus, and industry-leading CROs such as Covance Inc. (Labcorp R&D) and ICON plc.

Cameron_Glen_FutureMeds_edited.jpg
Cameron

Christophe Berthoux

Non-executive Director

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Christophe_Berthoux_FutureMeds.jpeg
Christophe

Chris Hannigan

Non-executive Director

Chris graduated from the University of Kent with a degree in Mathematics.  He has spent 35 years in the clinical trials industry having held senior positions at Roche, P&G, Covance and Kendle (now part of Syneos), where he served as UK Managing Director.  Chris joined Synexus in 2007 and ultimately held the role of Chief Commercial Officer until his retirement in 2016.  Chris is currently a non-executive director of Simbec-Orion.

Chris_Hannigan_FutureMeds.webp
Chris
bottom of page